Pure Global

BD BBL™ Sensi-Disc™ CEFTRIAXONE 30 µg - Indonesia BPOM Medical Device Registration

BD BBL™ Sensi-Disc™ CEFTRIAXONE 30 µg is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20301715520. The device is manufactured by BECTON DICKINSON CARIBE LTD. from United States, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. BECTON DICKINSON INDONESIA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
BD BBL™ Sensi-Disc™ CEFTRIAXONE 30 µg
Analysis ID: AKL 20301715520

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Country of Origin

United States

Authorized Representative

PT. BECTON DICKINSON INDONESIA

AR Address

Sampoerna Strategic Square South Tower 20th Floor Jl. Jend. Sudirman Kav 45-46

Registration Date

Feb 10, 2025

Expiry Date

Sep 13, 2029

Product Type

Diagnostic Equipment

Antimicrobial susceptibility test disc.

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing